Skip to content

Feldman Paul L Insider Trading -- Recent SEC Form 4 Transactions

Feldman Paul L (CIK 2050705) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-19). Recent activity: Buy AKTS (55,035 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-19Aktis Oncology, Inc. (AKTS)Chief Scientific OfficerBuy55,035$104,688

Source: SEC Form 4 filings · as of 2026-11-19